Company / Capital Expenditures
STANDARD BIOTOOLS INC. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$2.8M
FY2025
5-year range
$2.5M / $13.3M
FY2021-FY2025
Trend
-26.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 10 years, ranging from $372,000 in FY2020 to $13M in FY2022.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of +50.1%.
Declined from $4M to $3M over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -40.2%
- 5-Year CAGR
- +50.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +50.1%, indicating consistent growth.
- In FY2025, capital expenditures decreased 26.0% year-over-year.
- Peak capital expenditures was recorded in FY2022.
- Lowest capital expenditures in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.8M | -26.0% |
| FY2024 | $3.8M | +0.0% |
| FY2023 | $3.8M | -71.2% |
| FY2022 | $13.3M | +424.1% |
| FY2021 | $2.5M | +580.4% |
| FY2020 | $372.0K | -76.2% |
| FY2019 | $1.6M | -69.1% |
| FY2018 | $5.1M | +27.2% |
| FY2017 | $4.0M | -46.2% |
| FY2016 | $7.4M | +114.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026